The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population
Main Authors: | Débora Levy, Marcelo Bellesso, Pamela Oliveira-Souza, Felipe V. Maciel, Juliana Pereira, Sérgio P. Bydlowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2011-01-01
|
Series: | Clinics |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000500034 |
Similar Items
-
DLBCL 1L—What to Expect beyond R-CHOP?
by: Maike Stegemann, et al.
Published: (2022-03-01) -
FcγRIIa and FcγRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia
by: Marwa Zakaria, et al.
Published: (2023-01-01) -
Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
by: Guido Lancman, et al.
Published: (2018-01-01) -
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
by: A. Vera de Jonge, et al.
Published: (2023-05-01) -
A tail of two ITAMs: GPVI/FcRγ and FcγRIIa's role in platelet activation and thrombus stability
by: Keith B. Neeves
Published: (2021-07-01)